Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21808704 | 0.76 | IDO1 (0.61) | IDO1RAB9AHSD17B10POLBALOX15 | |
| SCHEMBL338205 | 0.73 | IDO1 (0.57) | IDO1RAB9AHSD17B10POLBALOX15 | |
| SCHEMBL11539110 | 0.73 | IDO1 (0.57) | IDO1RAB9AHSD17B10POLBALOX15 | |
| SCHEMBL476808 | 0.73 | IDO1 (0.57) | IDO1RAB9AHSD17B10POLBALOX15 | |
| SCHEMBL11502327 | 0.73 | IDO1 (0.57) | IDO1RAB9AHSD17B10POLBALOX15 | |
| SCHEMBL6185177 | 0.73 | IDO1 (0.57) | IDO1RAB9AHSD17B10POLBALOX15 | |
| SCHEMBL12661831 | 0.73 | IDO1 (0.57) | IDO1RAB9AHSD17B10POLBALOX15 | |
| SCHEMBL16711400 | 0.73 | IDO1 (0.57) | IDO1RAB9AHSD17B10POLBALOX15 | |
| SCHEMBL1754221 | 0.73 | IDO1 (0.57) | IDO1RAB9AHSD17B10POLBALOX15 | |
| SCHEMBL1405549 | 0.73 | IDO1 (1.00) | IDO1RAB9AHSD17B10POLBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3821249-B1 | SPECIFIC BINDING CHEMILUMINESCENT ASSAY | 3M INNOVATIVE PROPERTIES CO (US) | 2022-06-29 | — | — | EP | claimed |
| EP-2401392-B1 | SOLUTION PHASE HOMOGENEOUS ASSAYS | BECKMAN COULTER INC (US) | 2017-01-25 | — | — | EP | claimed |
| EP-0039483-B1 | PROCESS FOR THE PREPARATION OF 2-HYDROXY-BENZOTHIAZOLES | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-11-21 | — | — | EP | claimed |
| EP-0039483-A1 | Process for the preparation of 2-hydroxy-benzothiazoles | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-11-11 | — | — | EP | claimed |
| US-20170223964-A1 | Combination of Novel Nitrification Inhibitors and Herbicides as Well as Combination of (Thio)Phosphoric Acid Triamides and Herbicides | BASF SE (DE) | 2017-08-10 | — | — | US | disclosed |
| US-20170181435-A1 | Combination of Novel Nitrification Inhibitors and Biopesticides as Well as Combination of (Thio)Phosphoric Acid Triamides and Biopesticides | BASF SE (DE) | 2017-06-29 | — | — | US | disclosed |
| EP-0039483-B1 | PROCESS FOR THE PREPARATION OF 2-HYDROXY-BENZOTHIAZOLES | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-11-21 | — | — | EP | disclosed |
| EP-0039483-B1 | PROCESS FOR THE PREPARATION OF 2-HYDROXY-BENZOTHIAZOLES | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-11-21 | — | — | EP | disclosed |
| EP-0039483-A1 | Process for the preparation of 2-hydroxy-benzothiazoles | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-11-11 | — | — | EP | disclosed |
| EP-0039483-A1 | Process for the preparation of 2-hydroxy-benzothiazoles | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-11-11 | — | — | EP | disclosed |
| EP-0039483-A1 | Process for the preparation of 2-hydroxy-benzothiazoles | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-11-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170181435-A1 | Combination of Novel Nitrification Inhibitors and Biopesticides as Well as Combination of (Thio)Phosphoric Acid Triamides and Biopesticides | PRXL2A, NIT2, NAT1 | IDO1 343/4885RAB9A 3080/4885HSD17B10 2561/4885 |
| US-20170223964-A1 | Combination of Novel Nitrification Inhibitors and Herbicides as Well as Combination of (Thio)Phosphoric Acid Triamides and Herbicides | NAT1, PRXL2A, DDAH1 | IDO1 1282/4885RAB9A 3404/4885HSD17B10 1648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.